Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative

Cancer Clinical Trial

— DECAPAL  

Official title:

Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01593085
• Other study ID #: DECAPAL
• Status: Completed
• Phase: N/A
• First received: April 30, 2012
• Last updated: February 5, 2013
• Start date: April 2012
• Est. completion date: February 2013

Study information

• Verified date: April 2012
• Source: Centre Francois Baclesse
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
• Study type: Observational

Clinical Trial Summary

The investigators propose a study that aims to develop a methodology for assessing this risk and the psychological consequences of the malignancy in the palliative phase.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 55
• Est. completion date: February 2013
• Est. primary completion date: February 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient (s) age (s) 18 or more

• Patient (s) reach (s) of a cancer palliative stage

• Patient (s) hospital (s) in the palliative care service

• Patient (s) with cognitive function to an interrogation

• Patient (s) having a physical condition for an interview lasting 45 minutes

• Patient (s) that received clear information on the diagnosis and prognosis of their disease.

• Free and informed consent signed

Exclusion Criteria:

• Patient (s) age (s) under 18 years

• Patient (s) under supervision or unable to give informed consent

• Patient (s) whose cognitive functions do not allow an examination.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cancer

Intervention

Behavioral:
• interview with a doctor for evaluating suicide risk
patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk)

Locations

Country	Name	City	State
France	Centre François BACLESSE	Caen	Calvados

Sponsors (1)

Lead Sponsor	Collaborator
Centre Francois Baclesse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	assessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.	assessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.	at inclusion only, during hospitalization in palliative cares	No
Secondary	Evaluate the feasibility of a methodology for estimating the risk of suicide in patients with cancer admitted to a palliative care service	Evaluate the feasibility of a methodology for estimating the risk of suicide in patients with cancer admitted to a palliative care service Questionnaires used are HADS Questionary, Scale HAMILTON, Scale BECK and Scale DUCHER	at inclusion only, during hospitalization in palliative cares	No
Secondary	Assess the psychological impact of cancer pathology in patients in palliative	Assess the psychological impact of cancer pathology in patients in palliative by evaluating depression score (with HADS HAMILTON, BECK, DUCHER scales)	at inclusion only, during hospitalization in palliative cares	No
Secondary	Identify risk factors for suicide in this patient population	Identify risk factors for suicide in this patient population with evaluation of type of cancer, psychiatric history, family and social context, quality of life	at inclusion only, during hospitalization in palliative cares	No